Gainesville, Florida
United States
114
2026-08-20
The entities that hold a legal rights for patent applications filed by inventor SHAPIRO Gideon:
Gideon SHAPIRO from Gainesville, US has applied for patents for these inventions. The list has both pending applications and granted patents:
HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS
#2 | 2026-07-16TREATMENT OF AUTISM SPECTRUM DISORDERS, OBSESSIVE-COMPULSIVE DISORDER AND ANXIETY DISORDERS
#3 | 2024-07-25SALTS AND CRYSTALLINE FORMS OF (3E) 3-[O-[(PHOSPHONOOXY)METHYL]OXIME]-PREGN-4-ENE-3,20-DIONE AND RELATED USES
#4 | 2024-06-27TREATMENT OF AUTISM SPECTRUM DISORDERS, OBSESSIVE-COMPULSIVE DISORDER AND ANXIETY DISORDERS
#5 | 2024-06-06ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#6 | 2023-12-28CARM1 INHIBITORS AND USES THEREOF
#7 | 2023-09-07Carm1 inhibitors and uses thereof
#8 | 2023-05-043-(2-(Aminoethyl)-Indol-4-ol Derivatives, Methods of Preparation Thereof, and the Use as 5-HT2 Receptor Modulators
#9 | 2022-01-273,3-DIFLUOROPIPERIDINE CARBAMATE HETEROCYCLIC COMPOUNDS AS NR2B NMDA RECEPTOR ANTAGONISTS
#10 | 2021-07-22Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
#11 | 2021-05-27CARM1 INHIBITORS AND USES THEREOF
#12 | 2021-03-18Arginine methyltransferase inhibitors and uses thereof
#13 | 2020-09-243,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists
#14 | 2020-09-17Arginine methyltransferase inhibitors and uses thereof
#15 | 2019-10-17Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
#16 | 2019-10-03Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders
#17 | 2019-07-18ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#18 | 2019-05-09CARM1 inhibitors and uses thereof
#19 | 2019-04-04Arginine methyltransferase inhibitors and uses thereof
#20 | 2019-03-14ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#21 | 2019-01-24PRMT1 Inhibitors and Uses Thereof
#22 | 2018-12-063,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists
#23 | 2018-10-25Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists
#24 | 2018-10-11ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#25 | 2018-10-11Arginine methyltransferase inhibitors and uses thereof
#26 | 2018-10-04CARM1 inhibitors and uses thereof
#27 | 2018-09-27TREATMENT OF ANXIETY DISORDERS AND AUTISM SPECTRUM DISORDERS
#28 | 2018-09-27Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
#29 | 2018-09-20PRMT1 inhibitors and uses thereof
#30 | 2018-08-23PYRAZOLE DERIVATIVES AS ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#31 | 2018-06-213,3-difluoropiperidine carbamate heterocyclic compounds as NR2B NMDA receptor antagonists
#32 | 2018-04-19ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#33 | 2018-02-013,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists
#34 | 2017-11-16Imidazotriazinone compounds
#35 | 2017-11-09CARM1 inhibitors and uses thereof
#36 | 2017-11-02Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
#37 | 2017-10-26CARM1 INHIBITORS AND USES THEREOF
#38 | 2017-10-19SALTS, CO-CRYSTALS, AMORPHOUS FORMS, AND CRYSTALLINE FORMS OF A CO-ACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (CARM1) INHIBITOR
#39 | 2017-10-05CARM1 INHIBITORS AND USES THEREOF
#40 | 2017-10-05ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#41 | 2017-10-05ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#42 | 2017-09-21Arginine methyltransferase inhibitors and uses thereof
#43 | 2017-08-17PRMT1 inhibitors and uses thereof
#44 | 2017-07-27PRMT5 INHIBITORS AND USES THEREOF
#45 | 2017-07-27Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists
#46 | 2017-06-29PRMT1 inhibitors and uses thereof
#47 | 2017-06-01IMIDAZOTRIAZINONE COMPOUNDS
#48 | 2017-05-04Arginine methyltransferase inhibitors and uses thereof
#49 | 2017-04-13Difluoroethylpyridine derivatives as NR2B NMDA receptor antagonists
#50 | 2017-03-30ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#51 | 2017-03-02Arginine methyltransferase inhibitors and uses thereof
#52 | 2017-03-02CARM1 INHIBITORS AND USES THEREOF
#53 | 2017-01-12CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES
#54 | 2016-08-04Dibenzo[B,F][1,4]oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors
#55 | 2016-06-30Arginine methyltransferase inhibitors and uses thereof
#56 | 2016-06-30Arginine methyltransferase inhibitors and uses thereof
#57 | 2016-05-19Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
#58 | 2016-05-19Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
#59 | 2016-04-21Arginine methyltransferase inhibitors and uses thereof
#60 | 2016-03-17Pyrrolopyrimidine derivatives as NR2B NMDA receptor antagonists
#61 | 2016-02-251-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof
#62 | 2016-02-11CARM1 inhibitors and uses thereof
#63 | 2016-02-11PYRAZOLE DERIVATIVES AS PRMT1 INHIBITORS AND USES THEREOF
#64 | 2016-02-04ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#65 | 2016-01-28Arginine methyltransferase inhibitors and uses thereof
#66 | 2016-01-28Arginine methyltransferase inhibitors and uses thereof
#67 | 2016-01-14Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
#68 | 2015-12-035- AND 6-MEMBERED HETEROCYCLIC COMPOUNDS
#69 | 2015-11-12PHENOXYMETHYL HETEROCYCLIC COMPOUNDS
#70 | 2015-10-08PRMT1 inhibitors and uses thereof
#71 | 2015-10-011,2-disubstituted heterocyclic compounds
#72 | 2015-09-24Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
#73 | 2015-07-09Imidazotriazinone compounds
#74 | 2014-12-11Tetrasubstituted Benzenes
#75 | 2014-11-06Imidazotriazinone compounds
#76 | 2014-10-30Arginine methyltransferase inhibitors and uses thereof
#77 | 2014-10-23Arginine methyltransferase inhibitors and uses thereof
#78 | 2014-10-23Arginine methyltransferase inhibitors and uses thereof
#79 | 2014-09-25PRMT1 inhibitors and uses thereof
#80 | 2014-09-25PRMT1 inhibitors and uses thereof
#81 | 2014-09-25PRMT1 inhibitors and uses thereof
#82 | 2014-09-25Arginine methyltransferase inhibitors and uses thereof
#83 | 2014-09-25Arginine methyltransferase inhibitors and uses thereof
#84 | 2014-09-25Arginine methyltransferase inhibitors and uses thereof
#85 | 2014-09-25CARM1 inhibitors and uses thereof
#86 | 2014-09-04Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride
#87 | 2014-07-031,3,4-TRISUBSTITUTED BENZENES
#88 | 2014-06-05Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
#89 | 2014-05-29Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
#90 | 2014-03-20CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES
#91 | 2014-02-065- AND 6-MEMBERED HETEROCYCLIC COMPOUNDS
#92 | 2014-01-09Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
#93 | 2014-01-091,2-disubstituted heterocyclic compounds
#94 | 2013-11-28PDE-10 INHIBITORS
#95 | 2013-07-18Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate
#96 | 2013-06-27Tetrasubstituted benzenes
#97 | 2013-06-06Phenoxymethyl heterocyclic compounds
#98 | 2013-05-30Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
#99 | 2012-11-22Tetrasubstituted benzenes
#100 | 2012-09-131,2-disubstituted heterocyclic compounds
276084 ⎘